Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Trading Statement

27 Sep 2017 07:00

RNS Number : 8921R
Halma PLC
27 September 2017
 

Halma plc

 

Trading Update

 

27 September 2017

 

Trading Update

 

Halma, the leading safety, health and environmental technology group today releases its scheduled Trading Update, relating to trading for the period from 2 April 2017.

 

Halma made good progress in line with the Board's expectations. The improved rates of organic constant currency revenue and profit growth achieved in the second half of the last financial year have continued into the current year. Order intake was ahead of revenue and also ahead of the same period last year.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. Asia Pacific maintained strong growth, with good progress in the UK and Mainland Europe and a steady performance in the USA.

 

The Environmental & Analysis sector performed particularly well, benefitting from strong growth in Asia Pacific and the re-organisation in its Life Science and Research business during the first half of last year.

 

The improved performance achieved by the Process Safety sector in the second half of last year continued. Market diversification and rising demand from the US onshore energy market both contributed to significant growth over the prior year.

 

The Infrastructure Safety sector continued to achieve good growth as greater investment in new product development in recent years contributed towards increasing demand from Asia Pacific and Mainland Europe.

 

The Medical sector also achieved solid revenue growth, although profitability was lower due to increased investment in new product development and sales resources.

 

In August 2017, we announced the acquisitions of Cardios for an initial consideration of R$50m (£12.1m) and CASMED for $4.5m (£3.4m). Both businesses strengthen our Medical sector's blood pressure monitoring technology base, with Cardios also being Halma's first acquisition in Brazil. The integration of both businesses is progressing well.

 

Our M&A pipeline strengthened during the period. We continue to search for businesses in, or adjacent to, all four sectors and the additional sector resources added during 2016 have improved both the quantity and quality of our opportunities.

 

Cash generation was good and the Group's financial position remains strong.

 

The results for the half year ending 30 September 2017 will be released on 21 November 2017.

 

 

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDCUDDBGRL
Date   Source Headline
10th Aug 20053:23 pmRNSDirector/PDMR Shareholding
9th Aug 20052:30 pmRNSDirector/PDMR Shareholding
5th Aug 200512:44 pmRNSResult of AGM
3rd Aug 20057:00 amRNSAGM Statement
29th Jul 20054:53 pmRNSBlocklisting Interim Review
27th Jul 200511:11 amRNSHolding(s) in Company
22nd Jul 20054:05 pmRNSAnnual Information Update
19th Jul 20051:24 pmRNSAcquisition
12th Jul 20054:16 pmRNSDirector/PDMR Shareholding
12th Jul 20052:55 pmRNSHolding(s) in Company
6th Jul 20054:37 pmRNSDirector/PDMR Shareholding
5th Jul 20055:16 pmRNSAnnual Report and Accounts
1st Jul 20054:45 pmRNSHolding(s) in Company
29th Jun 20059:56 amRNSDirector Shareholding
24th Jun 20054:53 pmRNSDirector Shareholding
21st Jun 20057:00 amRNSFinal Results
6th Jun 20059:51 amRNSNotice of Board Meeting
28th Apr 20057:00 amRNSTrading Statement
1st Mar 20057:00 amRNSDirectorate Change
8th Feb 200510:15 amRNSDirector Shareholding
17th Jan 20059:30 amRNSBlocklisting Interim Review
17th Jan 20059:26 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.